Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187512 · ClinicalTrials.gov registry record
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
A clinical trial of HIV Infections, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT00187512 is a study of HIV Infections that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,500 participants, above the 441-participant average among 542 other HIV Infections trials with a reported enrollment target (467% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00187512, a study of HIV Infections, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infection, progression, non-progression, response to treatment, control of HIV-1 virus, and evolution of drug resistance.
Conditions Studied
Study Locations (1)
California
- San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2000-03 |
| Est. Completion | 2033-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187512
The ClinicalTrials.gov registry entry for NCT00187512 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 441-participant average among 542 other HIV Infections trials with a reported enrollment target (467% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00187512 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00187512 about?
NCT00187512 is a clinical study titled "SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era". SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infecti...
What is the current status of trial NCT00187512?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2000-03. Estimated completion is 2033-12.
What conditions does trial NCT00187512 study?
This clinical trial studies the following conditions: HIV Infections.
Who is sponsoring clinical trial NCT00187512?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00187512 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.